Vima Therapeutics operates as a biotechnology company.
Vima Therapeutics has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in March 2026.
Vima Therapeutics's investors include Canaan Partners, Frazier Life Sciences, Atlas Venture, Access Industries.
Vima Therapeutics is headquartered in Cambridge, United States.
Vima Therapeutics operates as a biotechnology company.
Vima Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vima Therapeutics — Funding & Investors." VCBacked, March 11, 2026, https://www.vcbacked.co/company/vima-therapeutics. Accessed November 14, 2026.
VCBacked. (2026). Vima Therapeutics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/vima-therapeutics
{{cite web |title=Vima Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vima-therapeutics |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Vima Therapeutics? Request a listing update